← Back
$KURA All transactions

Kura Oncology, Inc.

▲ BUY
10 / 10

Conviction

$ Value

$410K

Shares

50,000

Price

$8

Filed

Sep 9

Why this score? (10/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • % of holdings >= 20% (+2)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

WILSON TROY EDWARD

Title

President & CEO

CIK

0001589597

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-08

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

100,968

Footnotes

This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0001415889-25-023974

Form Type

4

Issuer CIK

0001422143

WILSON TROY EDWARD's History

Date Ticker Type Value
2026-03-23 KURA M $38K
2026-03-23 KURA M $0
2026-01-02 KURA A $0
2025-11-13 KURA A $0
2025-09-29 KURA $327K
2025-09-27 KURA A $0
2025-09-08 KURA $410K
2025-09-05 RNA M $181K
2025-09-05 RNA $725K
2025-09-05 RNA $750K

Other Insiders at KURA (90d)

Insider Bought Sold Last
WILSON TROY EDWARD
President and CEO
2026-03-23
FORD KATHLEEN
Chief Operating Officer
$15K 2026-01-27
Bair Teresa Brophy
Chief Legal Officer
$95K 2026-01-27
DOYLE THOMAS JAMES
SVP, Finance & Accounting
$60K 2026-01-27
Powl Brian T.
Chief Commercial Officer
$54K 2026-01-27
Leoni Mollie
Chief Medical Officer
$69K 2026-01-27
Burrows Francis
Chief Scientific Officer
$11K 2026-01-27